Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

PHASE4CompletedINTERVENTIONAL

Enrollment

380

Participants

Timeline

Start Date

July 13, 2015

Primary Completion Date

November 15, 2016

Study Completion Date

November 25, 2016

Conditions

Essential HypertensionType 2 Diabetes Mellitus

Interventions

DRUG

Azilsartan Medoxomil

Azilsartan medoxomil tablets

Trial Locations (11)

Hong Kong

Changhua County

Kaohsiung City

Taichung

Tainan City

Taipei

Taoyuan

Bangkok

Chiang Mai

Khon Kaen

Pathum Thani